SkIN Canada is funded by the Canadian Institution of Health Research
Ms. Veronique Moulin
The advancement of biomedical research including regenerative medicine, tissue engineering reconstruction of different tissues and organs as well as the understanding of physiological, pathophysiological mechanisms and pharmacotoxicological and cosmetological analyzes.
Skin conditions represented:
Dr. Vincent Piguet
We are engaged in translational research of inflammatory dermatoses and perturbation of immune regulation and microbial communities at associated disease sites.
CTTB Biobank and Registry for Atopic dermatitis
Dr. Carolyn Jack
The Transdisciplinary Centre for Biological Therapies (Centre Transdisciplinaire de Thérapies Biologiques or CTTB) is a multidisciplinary, integrated approach for patients who are receiving therapies directed at the immune system. The CTTB Biobank and Registry for Atopic dermatitis has been created to collect and store blood, skin tissue and other types of biological samples, as well as clinical information, for current and future research purposes.
To identify the impact of various treatments for dermatitis on patient symptoms, quality of life and disease outcome.
To characterize (including potential sequencing) skin lesions and matched normal tissues at the molecular and cellular level (the cells, the DNA, RNA and proteins, as well as their regulatory factors), to help better understand disease biology, prognosis and response to therapy, with a potential to identify new targets for improved treatments.
To characterize cells, proteins and genetic material (RNA and DNA) in the blood or other bodily fluids to identify characteristics that may act to identify specific kinds of skin diseases, or to predict response to therapy or disease outcome.
To characterize biomarkers, including those related to microbiome (bacteria that live on or in humans) to identify potential disease markers, markers of response to therapy or prognostic markers.
This is a test